ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner
Shanghai, China (March 24, 2017) – ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced today the intent for a strategic corporate restructuring. ShangPharma will be consolidating the Contract Research Organizations (CRO) and Contract Manufacturing Organizations (CMO) under […]
